Report Categories
View AllRecent Articles
View All
INKT MiNK Therapeutics posts narrower Q4 2025 loss than expected shares drop 978 percent on zero revenue
TBPH Theravance Biopharma notches 669 Q4 2025 revenue growth despite large EPS miss stock dips marginally
US Airline Merger Antitrust Ruling Analysis
Borr Drilling BORR Stock Stability Assessment Q4 2025 Profit Surprises
What NaaS NAAS bond yields suggest about risk NaaS posts 100 EPS miss no Q3 revenue disclosed
RFAI RF declines to share latest quarterly earnings figures while evaluating AI sector acquisition targets
The surprise hidden in Coterra CTRA last earnings report Coterra posts 206 EPS miss on energy price pressure
FIBK First posts narrow Q1 2026 EPS miss shares tick slightly higher in todays trading session
GNRC Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction
Pacific PCG Q1 2026 Beat Revenue NA EPS Exceeds by Significant
COOTW Warrants See Modest Gains Remain Near Floor
Synthetic GJO Idles at 2422 Low Volume Session 20260521